Ponce School of Medicine-Moffitt Cancer Center partnership (2/2)

庞塞医学院与莫菲特癌症中心合作 (2/2)

• 批准号: 8550008
• 负责人: Jaime L Matta
• 金额: $ 132.06万
• 依托单位: H. LEE MOFFITT CANCER CTR & RES INST
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-09-24 至 2017-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8550008
• 关键词: Address; Basic Science; Biological Markers; Biology; Cancer Center; Cancer Patient; Clinical; Clinical Oncology; Clinical Research; Clinical Trials; Collaborations; Communities; Community Outreach; Development; Emerging Technologies; Evaluation; FOLH1 gene; Faculty; Florida; Genetic; Health; Hispanics; Lead; Learning; Malignant Neoplasms; Medicine; Mentors; Oncologist; Outcome; Outreach Research; Patients; Population; Problem Solving; Procedures; Puerto Rican; Puerto Rico; Research; Research Infrastructure; Research Personnel; Research Project Grants; Resources; Science; Scientist; Services; Site; Technology; Therapeutic Clinical Trial; Time; Tissue Banking; Tissue Banks; Tissues; Training; Translational Research; Tumor Bank; Underserved Population; anticancer research; biobank; cancer care; cancer health disparity; career; experience; improved; insight; medical schools; oncology; oncology service; outreach program; public health relevance

DESCRIPTION (provided by applicant): The objectives to expand the Ponce School of Medicine-Moffitt Cancer Center Partnership are to: 1) Maintain a comprehensive administrative infrastructure and procedures to perform critical evaluations of the projects and cores, solve problems, maintain quality, and strategically plan for continued expansion of the Partnership, and provide support for the development of the successful careers of the Partnership faculty. 2) Bring together in close collaboration basic scientists at PSM and MCC to conduct research projects: this will provide scientists at PSM access to experienced cancer research scientists as collaborators and mentors as well as advanced technologies, to advance their careers and the impact of their science. Reciprocally, the MCC scientists will benefit from becoming involved in new research projects focused on the unique biology of Hispanic patient cancers. 3) Develop a comprehensive training pipeline to produce a cadre of cancer translational research scientists, both basic and clinical, to address the shortage of Hispanic academicians on the faculties of academic health centers in Puerto Rico and the mainland US. This will produce scientists who are knowledgeable about the issues related to Hispanic cancer health disparities and motivated to perform research to address these disparities. 4) Conduct rigorous outreach research to learn the most effective ways of communicating cancer related information, and expand community outreach programs incorporating these discoveries. This will improve participation in clinical research and biobanking, and the overall health of the Hispanic community in Florida served by the MCC and in Puerto Rico. 5) Expand at the PSM tertiary referral clinical oncology services, educational opportunities for community oncologists and oncology fellows, and patient access to clinical trials to improve cancer care for the currently underserved population of Southwest Puerto Rico. 6) Establish for the first time a high quality tumor bank of tissues from Puerto Rican cancer patients that will provide a unique and valuable resource for the basic research scientists to make discoveries that are specific for Hispanic cancer patients that will provide insight for th development of biomarker driven personalized medicine for this population.

描述（申请人提供）：扩展Ponce医学学院癌症中心合作伙伴关系的目标是：1）维护全面的行政基础设施和程序，以对项目和核心进行批判性评估，解决问题，维持质量和战略性计划，以持续扩展合作伙伴关系，并为成功护理人员的成功提供支持。 2）在PSM和MCC的密切合作基础科学家中汇集了研究项目：这将为PSM的科学家提供经验丰富的癌症研究科学家作为合作者和导师以及高级技术的访问，以促进其职业和科学的影响。互惠地，MCC科学家将受益于参与新的研究项目，该项目专注于西班牙裔患者癌的独特生物学。 3）开发一条全面的培训管道，以建立基本和临床的癌症转化研究科学家的干部，以解决西班牙裔院士在波多黎各和美国大陆的学术卫生中心学院的短缺。这将使科学家了解与西班牙癌症健康差异有关的问题，并有动力进行研究以解决这些差异。 4）进行严格的外展研究，以学习传达与癌症相关信息的最有效方法，并扩大结合这些发现的社区外展计划。这将改善参与临床研究和生物群的参与，以及由MCC和波多黎各服务的佛罗里达州西班牙裔社区的整体健康。 5）在PSM第三级推荐临床肿瘤学服务，社区肿瘤学家和肿瘤学研究员的教育机会以及患者进入临床试验，以改善当前西南波多黎各人口的癌症护理。 6）首次建立波多黎各人的高质量肿瘤组织 癌症患者将为基础研究科学家提供独特而有价值的资源，以便为西班牙裔癌症患者提供特定的发现，这些发现将为该人群提供生物标志物驱动的个性化医学的洞察力。